Thomas Pusl

1.3k total citations
32 papers, 869 citations indexed

About

Thomas Pusl is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Thomas Pusl has authored 32 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Thomas Pusl's work include Liver Diseases and Immunity (9 papers), Drug Transport and Resistance Mechanisms (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Thomas Pusl is often cited by papers focused on Liver Diseases and Immunity (9 papers), Drug Transport and Resistance Mechanisms (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Thomas Pusl collaborates with scholars based in Germany, United States and Netherlands. Thomas Pusl's co-authors include Ulrich Beuers, Michael H. Nathanson, Christian Rust, Keiji Hirata, Jonathan A. Dranoff, Allison F. O’Neill, Andreas E. Kremer, Ronald Oude‐Elferink, Gerald Denk and G. Paumgartner and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Thomas Pusl

32 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Pusl Germany 16 300 275 275 248 238 32 869
Eduardo Martínez‐Ansó Spain 13 262 0.9× 242 0.9× 223 0.8× 275 1.1× 240 1.0× 21 866
Shigenari Hozawa Japan 11 167 0.6× 193 0.7× 159 0.6× 299 1.2× 159 0.7× 18 714
Samuel Martín‐Vílchez Spain 17 91 0.3× 130 0.5× 360 1.3× 244 1.0× 351 1.5× 42 920
Rie Irie Japan 14 229 0.8× 70 0.3× 285 1.0× 186 0.8× 390 1.6× 56 827
Ruth Alcolado United Kingdom 8 159 0.5× 53 0.2× 332 1.2× 152 0.6× 278 1.2× 10 792
Gábor Firneisz Hungary 18 187 0.6× 233 0.8× 77 0.3× 238 1.0× 240 1.0× 46 977
Akitaka Hisatomi Japan 19 525 1.8× 141 0.5× 146 0.5× 414 1.7× 171 0.7× 47 1.2k
Takahiro Nishio Japan 15 236 0.8× 146 0.5× 392 1.4× 169 0.7× 344 1.4× 66 796
Annika Sommerfeld Germany 13 200 0.7× 255 0.9× 180 0.7× 159 0.6× 171 0.7× 24 553

Countries citing papers authored by Thomas Pusl

Since Specialization
Citations

This map shows the geographic impact of Thomas Pusl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pusl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pusl more than expected).

Fields of papers citing papers by Thomas Pusl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pusl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pusl. The network helps show where Thomas Pusl may publish in the future.

Co-authorship network of co-authors of Thomas Pusl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Pusl. A scholar is included among the top collaborators of Thomas Pusl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Pusl. Thomas Pusl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pusl, Thomas, et al.. (2017). Gynecomastia: Look Beyond the Obvious. The American Journal of Medicine. 130(10). e439–e440. 3 indexed citations
2.
Stallhofer, Johannes, Gerald Denk, Jürgen Glas, et al.. (2011). Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis. Digestion. 84(1). 29–35. 6 indexed citations
3.
Denk, Gerald, Charalampos Aslanidis, G. Schmitz, Klaus G. Parhofer, & Thomas Pusl. (2010). Association of HDL Deficiency with a Novel Mutation in the ABCA1 Gene. Experimental and Clinical Endocrinology & Diabetes. 119(1). 53–55. 2 indexed citations
4.
Pusl, Thomas, Uli C. Broedl, Klaus G. Parhofer, & Carsten Otto. (2009). Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease. Clinical Hemorheology and Microcirculation. 41(2). 137–142. 7 indexed citations
5.
Paumgartner, G. & Thomas Pusl. (2008). Medical Treatment of Cholestatic Liver Disease. Clinics in Liver Disease. 12(1). 53–80. 27 indexed citations
6.
Beuers, Ulrich, et al.. (2008). Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?. Clinical Reviews in Allergy & Immunology. 36(1). 52–61. 24 indexed citations
7.
Bogdanos, Dimitrios P., Thomas Pusl, Christian Rust, Diego Vergani, & Ulrich Beuers. (2008). Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis. Journal of Hepatology. 49(3). 466–473. 40 indexed citations
8.
Pusl, Thomas & Ulrich Beuers. (2007). Intrahepatic cholestasis of pregnancy. Orphanet Journal of Rare Diseases. 2(1). 26–26. 124 indexed citations
9.
Pusl, Thomas, et al.. (2007). Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1. Biochemical and Biophysical Research Communications. 367(1). 208–212. 23 indexed citations
10.
Pusl, Thomas. (2006). Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World Journal of Gastroenterology. 12(22). 3487–3487. 56 indexed citations
11.
Pusl, Thomas, et al.. (2006). Malacoplakia in a renal transplant recipient. European Journal of Internal Medicine. 17(2). 133–135. 12 indexed citations
12.
Seiderer, Julia, et al.. (2006). Vigilanzminderung und ausgeprägte Hyponatriämie bei einer 67-jährigen Patientin. Der Internist. 47(6). 623–628. 1 indexed citations
13.
Pusl, Thomas & Ulrich Beuers. (2005). Extrahepatic Manifestations of Cholestatic Liver Diseases: Pathogenesis and Therapy. Clinical Reviews in Allergy & Immunology. 28(2). 147–158. 15 indexed citations
14.
Pusl, Thomas & Michael H. Nathanson. (2004). The role of inositol 1,4,5-trisphosphate receptors in the regulation of bile secretion in health and disease. Biochemical and Biophysical Research Communications. 322(4). 1318–1325. 20 indexed citations
15.
Pusl, Thomas, et al.. (2004). A case of systemic mastocytosis associated with severe osteoporosis and pathologic fractures. European Journal of Internal Medicine. 15(8). 537–539. 4 indexed citations
16.
Thompson, Mayerson, Viviane A. Andrade, Thomas Pusl, et al.. (2003). Inhibition of the TEF/TEAD transcription factor activity by nuclear calcium and distinct kinase pathways. Biochemical and Biophysical Research Communications. 301(2). 267–274. 26 indexed citations
17.
Hirata, Keiji, Thomas Pusl, Allison F. O’Neill, Jonathan A. Dranoff, & Michael H. Nathanson. (2002). The type II inositol 1,4,5-trisphosphate receptor can trigger Ca2+ waves in rat hepatocytes. Gastroenterology. 122(4). 1088–1100. 108 indexed citations
18.
Pusl, Thomas, Tracy L. Zimmerman, Lei Zhang, et al.. (2002). Epidermal Growth Factor-mediated Activation of the ETS Domain Transcription Factor Elk-1 Requires Nuclear Calcium. Journal of Biological Chemistry. 277(30). 27517–27527. 95 indexed citations
19.
Leite, M. Fátima, Keiji Hirata, Thomas Pusl, et al.. (2002). Molecular Basis for Pacemaker Cells in Epithelia. Journal of Biological Chemistry. 277(18). 16313–16323. 38 indexed citations
20.
Krause, Günter, et al.. (1997). Applications of consensus polymerase chain reaction with subsequent electrophoretic distinction of amplificates. Electrophoresis. 18(7). 1098–1102. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Martínez‐Ansó Breakdown of academic impact, for papers by Shigenari Hozawa Breakdown of academic impact, for papers by Samuel Martín‐Vílchez Breakdown of academic impact, for papers by Rie Irie Breakdown of academic impact, for papers by Ruth Alcolado Breakdown of academic impact, for papers by Gábor Firneisz Breakdown of academic impact, for papers by Akitaka Hisatomi Breakdown of academic impact, for papers by Takahiro Nishio Breakdown of academic impact, for papers by Annika Sommerfeld
Rankless by CCL
2026